岭南现代临床外科
嶺南現代臨床外科
령남현대림상외과
LINGNAN MODERN CLINICS IN SURGERY
2014年
3期
235-238
,共4页
李悦%张大伟%薛平%卢海武%郑强%曹良启
李悅%張大偉%薛平%盧海武%鄭彊%曹良啟
리열%장대위%설평%로해무%정강%조량계
胆管癌%光动力疗法%内镜治疗%生存期
膽管癌%光動力療法%內鏡治療%生存期
담관암%광동력요법%내경치료%생존기
Cholangiocarcinoma%Photodynamic therapy%Endoscopic treatment%Survival time
目的:探讨内镜光动力微创疗法(PDT)联合支架置入术治疗胆管癌的临床疗效。方法将2005年10月至2009年6月我院收治的62例胆管癌患者分为两组,对照组32例,给予内镜下支架置入术;治疗组30例,在支架置入术的基础上,给予内镜下光动力治疗。对62例晚期胆管癌患者的生存时间及生活质量进行随访。结果经过3年以上的随访,治疗组中位生存时间18个月,1、2、3年生存率分别为63.3%、43.3%及20.0%;对照组中位生存时间8个月,1、2、3年生存率分别为43.8%、25.0%及9.4%,生活质量FACT-Hep量表术后6个月、9个月及12个月,治疗组量表总分明显高于对照组(P<0.05),术前胆红素水平、远处转移及治疗方法是影响胆管癌患者生存期的独立预后因子。结论内镜光动力微创疗法(PDT)联合支架置入术提高了胆管癌患者的生存率,改善了生活质量,是胆管癌一种有效的治疗方法。
目的:探討內鏡光動力微創療法(PDT)聯閤支架置入術治療膽管癌的臨床療效。方法將2005年10月至2009年6月我院收治的62例膽管癌患者分為兩組,對照組32例,給予內鏡下支架置入術;治療組30例,在支架置入術的基礎上,給予內鏡下光動力治療。對62例晚期膽管癌患者的生存時間及生活質量進行隨訪。結果經過3年以上的隨訪,治療組中位生存時間18箇月,1、2、3年生存率分彆為63.3%、43.3%及20.0%;對照組中位生存時間8箇月,1、2、3年生存率分彆為43.8%、25.0%及9.4%,生活質量FACT-Hep量錶術後6箇月、9箇月及12箇月,治療組量錶總分明顯高于對照組(P<0.05),術前膽紅素水平、遠處轉移及治療方法是影響膽管癌患者生存期的獨立預後因子。結論內鏡光動力微創療法(PDT)聯閤支架置入術提高瞭膽管癌患者的生存率,改善瞭生活質量,是膽管癌一種有效的治療方法。
목적:탐토내경광동력미창요법(PDT)연합지가치입술치료담관암적림상료효。방법장2005년10월지2009년6월아원수치적62례담관암환자분위량조,대조조32례,급여내경하지가치입술;치료조30례,재지가치입술적기출상,급여내경하광동력치료。대62례만기담관암환자적생존시간급생활질량진행수방。결과경과3년이상적수방,치료조중위생존시간18개월,1、2、3년생존솔분별위63.3%、43.3%급20.0%;대조조중위생존시간8개월,1、2、3년생존솔분별위43.8%、25.0%급9.4%,생활질량FACT-Hep량표술후6개월、9개월급12개월,치료조량표총분명현고우대조조(P<0.05),술전담홍소수평、원처전이급치료방법시영향담관암환자생존기적독립예후인자。결론내경광동력미창요법(PDT)연합지가치입술제고료담관암환자적생존솔,개선료생활질량,시담관암일충유효적치료방법。
Objective To evaluate the efficacy of endoscopic photodynamic therapy combined with stent implantation on cholangiocarcinoma..Methods Sixty-two cases of patients with cholangioc-arcinoma from October 2005 to June 2009 in our hospital were divided into two groups ,.32 cases in the control group were treated by endoscopic stent placement,.and 30 cases in the treatment group were treated with the endoscopic stent placement combined with photodynamic therapy. The follow-up was done in 62 cases,.including survival time and quality of life..Results After 3years of follow-up, the median overall survival time of treatment group was 18 months,.the 1-,.2- and 3-year survival rate were 63.3%, 43.3%, and 20.0%, respectively. The median overall survival time of control group was 8 months, the 1-, 2- and 3-year survival rate were 43.8%, 25.0% and 9.4%, respectively. The total score of FACT-Hep scales in treatment group were higher than those in control group at postoperative 6 months,.9 months and 12 months (P<0.05). Cox multivariate analysis demonstrated that among the factors analyzed,.the level of bilirubin,.lymph node status,.and therapeutic method were independent prognostic factors for overall survival in patients with cholangiocarcinoma. .Conclusion Endoscopic photodynamic therapy combined with stent implantation improves survival and quality of life , and is an effective treatment for patients with cholangiocarcinoma.